Advertisement
Screener

INNOVIVA, INC. (INVA) Goodwill

2.8 / 5 stars · 68/120 Roast Me

INNOVIVA, INC. Goodwill

INNOVIVA, INC. (INVA) had Goodwill of $17.91 million as of 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:Goodwill · last filed 2026-08-05

  • 2026-06-30: Goodwill $17.91M.
  • 2026-03-31: Goodwill $17.91M.
  • 2025-12-31: Goodwill $17.91M.
  • 2025-09-30: Goodwill $17.91M.
Period endGoodwill
2026-06-30$17.91M
10-Q · filed 2026-08-05
2026-03-31$17.91M
10-Q · filed 2026-05-06
2025-12-31$17.91M
10-Q · filed 2026-08-05
2025-09-30$17.91M
10-Q · filed 2025-11-05
2025-06-30$17.91M
10-Q · filed 2025-08-06
2025-03-31$17.91M
10-Q · filed 2025-05-07
2024-12-31$17.91M
10-K · filed 2026-02-25
2024-09-30$17.91M
10-Q · filed 2024-11-06
2024-06-30$17.91M
10-Q · filed 2024-07-31
2024-03-31$17.91M
10-Q · filed 2024-05-08
2023-12-31$17.91M
10-K · filed 2025-02-26
2023-09-30$17.91M
10-Q · filed 2023-11-01
2023-06-30$14.88M
10-Q · filed 2023-08-02
2023-03-31$27.95M
10-Q · filed 2023-05-09
2022-12-31$26.71M
10-K/A · filed 2024-03-05
2022-09-30$15.99M
10-Q · filed 2022-11-09
2022-06-30$5.54M
10-Q · filed 2022-07-27
2022-03-31$5.54M
10-Q · filed 2022-05-05
2021-12-31$0.00
10-K · filed 2023-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10